Informed Consent Debate Resurfaces Over Medicare Coverage With Evidence Development
This article was originally published in The Gray Sheet
Executive Summary
The debate over whether informed consent is necessary and whether it can be valid in the context of Medicare coverage-with-evidence-development determinations came up in public comments to CMS on its pending national coverage policy for transcatheter aortic valve replacement.